FEATURES OF STRUCTURAL-PHASE TRANSFORMATIONS IN KIDNEY STONES CONTAINING U-235,238 ISOTOPES
Problems of Atomic Science and Technology · 12.06.2026 · 165
DOI: 10.46813/2026-163-165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Atomic Science and Technology, online erschienen am 12.06.2026. Verfasst von O.P. Bereznyak und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
To study the phase composition, degree of ordering, and crystallinity of the structure of uranium-containing kidney stones, a crystal-optical method combined with IR spectroscopy was used. Measurement of the optical properties of these kidney stones in urolithiasis provides information on their structural features, the intensity of IR absorption bands, and phenomena associated with the passage of light waves through crystals. Significant changes in the studied parameters were detected in kidney stones over time. It was shown that the presence of uranium in the composition of kidney stones leads to a simplification of their structure: crystalline components were identified – weddelite (crystalline calcium oxalate dihydrate СаС2О4∙2Н2О, ~ 40…50% by volume) and whewellite (crystalline calcium oxalate monohydrate СаС2О4∙Н2О, ~ 50…60% by volume).
Zitieren
APA
Bereznyak, O., Kolupaev, S., & Medvedeva, O. (2026). FEATURES OF STRUCTURAL-PHASE TRANSFORMATIONS IN KIDNEY STONES CONTAINING U-235,238 ISOTOPES. Problems of Atomic Science and Technology, 165. https://doi.org/10.46813/2026-163-165
Vancouver
Bereznyak O, Kolupaev S, Medvedeva O. FEATURES OF STRUCTURAL-PHASE TRANSFORMATIONS IN KIDNEY STONES CONTAINING U-235,238 ISOTOPES. Problems of Atomic Science and Technology. 2026:165. doi:10.46813/2026-163-165
BibTeX
@article{Bereznyak2026,
author = {Bereznyak, O.P. and Kolupaev, S.M. and Medvedeva, O.P.},
title = {FEATURES OF STRUCTURAL-PHASE TRANSFORMATIONS IN KIDNEY STONES CONTAINING U-235,238 ISOTOPES},
journal = {Problems of Atomic Science and Technology},
year = {2026},
pages = {165},
doi = {10.46813/2026-163-165}
}
EUVIMED